Kanser

KanserKanser
K

Kanser

Matches patients with active oncology clinical trials in Turkey using natural language search and biomarker matrices.

DR 0Active
Rate

About

Kanser.AI is an AI-powered clinical research matching platform designed for oncology professionals in Turkey. It enables physicians to quickly match cancer patients with active oncology clinical trials using natural language search, a universal stage and biomarker matrix, and a live data pool of current protocols. The platform aims to provide a physician-friendly decision support tool by simplifying the identification of suitable trials based on patient profiles.
Frequently asked

What does Kanser do?

Kanser.AI is an AI-powered clinical research matching platform designed for oncology professionals in Turkey. It enables physicians to quickly match cancer patients with active oncology clinical trials using natural language search, a universal stage and biomarker matrix, and a live data pool of current protocols. The platform aims to provide a physician-friendly decision support tool by simplifying the identification of suitable trials based on patient profiles.

What industry does Kanser operate in?

Kanser operates in HealthTech, MedTech, Clinical Trials, Oncology, Patient Matching, Natural Language Processing.

Comments

No comments yet. Be the first to share your take.